Kansas City Chiefs fans have hit out at the franchise after it was confirmed they will leave Arrowhead Stadium for a new $3 billion domed arena in Kansas. The franchise confirmed on Monday that they ...

After more than five decades at Arrowhead Stadium in Kansas City, Mo., the Chiefs are expected to cross the border to play at a proposed new stadium in Kansas. "Today is an extraordinary day in the ...

TOPEKA, Kan. -- The Kansas City Chiefs announced Monday that they will leave Arrowhead Stadium, their longtime home venue in Missouri, for a new, $3 billion domed stadium that will be built across the ...

A house in Lake Arrowhead with spalike amenities, a Craftsman in Mill Valley and a contemporary house in Laguna Beach. By Angela Serratore This five-bedroom, five-bathroom house, which includes lake ...

On Monday, the Kansas City Chiefs announced they will be leaving Arrowhead Stadium in favor of a new, domed stadium that will be built across the state line in Kansas. The stadium is expected to be ...

KANSAS CITY, Kan. -- The Kansas City Chiefs appear to be mere days away from taking a big step toward a move across the state line, and eventually leaving their longtime home at Arrowhead Stadium in ...

The CEO of Helldivers 2 developer Arrowhead has responded to fan concern about the choice of Justin Lin as the director of the Helldivers movie, after it emerged he leaned into not being a gamer for ...

The FDA approval of the siRNA drug Redemplo caps off a tumultuous 12 months for Arrowhead, whose partnership with Sarepta caused its own stock to drop during the gene therapy maker’s safety troubles ...

JEFFERSON CITY, Mo. (AP) — As the Kansas City Chiefs weigh whether to play future games in a renovated Arrowhead Stadium or a proposed dome in Kansas, Missouri Gov. Mike Kehoe on Tuesday floated a ...

- ARO-DIMER-PA is designed to selectively silence the expression of two genes with a single RNAi molecule using Arrowhead’s proprietary TRiM TM technology - In preclinical studies ARO-DIMER-PA ...

Arrowhead Pharmaceuticals Files CTA for Investigational ARO-DIMER-PA – the First Dual Functional RNAi Therapeutic for the Treatment of Mixed Hyperlipidemia - ARO-DIMER-PA is designed to selectively ...